Concordance between serum and transcutaneous bilirubin levels with the Bilispect® Online publication date: Tue, 06-Nov-2018
by Adriana Montealegre; Nathalie Charpak; Zandra Grosso; Yaris Vargas; Julieta Villegas
International Journal of Biomedical Engineering and Technology (IJBET), Vol. 28, No. 4, 2018
Abstract: Screening and follow-up of neonatal hyperbilirubinemia has been done with the use of bilirubin serum levels. This method is invasive and exposes patients to anaemia. A transcutaneous measurement, the Bilispect®, offers an attractive alternative. The concordance between serum and transcutaneous bilirubin levels using the Bilispect®, and the correlation of these values according to prematurity and phototherapy in Latin American neonates were estimated. Simultaneous measurement of serum and transcutaneous bilirubin levels were taken in 239 Colombian new-borns. Concordance was estimated with the Bland-Altman method and Lin concordance index. The Lin concordance index was 0.747 (95% CI 0.691, 0.804). According to Bland-Altman, mean difference was −0.151 (SD 2.510; 95% limits of agreement −5.070, 4.769). Pearson's correlation was 0.79 without phototherapy, 0.72 with phototherapy, 0.76 in preterm and 0.73 in term new-borns. This device has a high potential due to its easy handling. Results are useful to improve the software performance.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Biomedical Engineering and Technology (IJBET):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com